'Reducing Cardiovascular Risk: New Insights From ONTARGET®' Webcast Now Available
Hypertension 2008, the joint congress of the European Society of Hypertension and the International Society of Hypertension, from 14th to 19th June 2008, was held in Berlin, Germany. During the Boehringer Ingelheim and Bayer Schering Pharma satellite symposium 'Reducing Cardiovascular Risk: New Insights From ONTARGET®' renowned international speakers presented the latest findings from the landmark trial ONTARGET®. The entire session is now available as a webcast under the following link.
Exclusive ONTARGET® Trial Results Webcast
You can now hear the ONTARGET® results straight from the lead investigator Professor Salim Yusuf by viewing our exclusive webcast.
'ONTARGET®: New Standard in Cardio and Vascular Protection' Webcast Available
The 'ONTARGET®: New Standard in Cardio and Vascular Protection' sponsored symposium, by Boehringer Ingelheim and Bayer Schering Pharma, was held in Berlin on June 18th at Hypertension 2008, the joint congress of the European Society of Hypertension and the International Society of Hypertension . A panel of international experts presented the latest findings from the landmark ONTARGET® trial, discussed the role of ARBs in stroke prevention in the light of the results of another landmark trial, PRoFESS®, and evaluated the role of ARBs in daily clinical practice. The entire session is now available as a webcast under the following link.
Free ONTARGET® Online Publication Available
You can now download your free e-reprint of the New England Journal of Medicine (NEJM) online publication of The ONTARGET® Trial initial results. Registration required.
Calendar
Tools and Downloads
My Alerts
You will shortly be able to create your own personal alerts service bringing the latest ONTARGET® news and updates direct to your inbox. Watch this space for more information.
